Stock-Based Compensation (Details 4) (USD $) In Millions, except Share data, unless otherwise specified	0 Months Ended	3 Months Ended	6 Months Ended
	Jun. 02, 2014	Jun. 30, 2014	Jun. 30, 2014
Stock-based compensation
Number of shares of Theravance Biopharma issued for every share of Theravance	0.286
Incremental stock-based compensation expense arising out of spin-off		$ 1.2
Stockholders' Equity
Awards exercised (in shares)			79,000
Weighted-average exercise price of awards exercised (in dollars per share)			$ 12.89
Total cash proceed			1.0
Discontinued operation
Stock-based compensation
Incremental stock-based compensation expense arising out of spin-off		$ 0.9